Swiss National Bank Reduces Holdings in Alignment Healthcare, Inc. $ALHC

Swiss National Bank lowered its holdings in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 1.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 185,700 shares of the company’s stock after selling 1,900 shares during the period. Swiss National Bank owned about 0.09% of Alignment Healthcare worth $3,458,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ALHC. MCF Advisors LLC raised its position in Alignment Healthcare by 87.6% during the first quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock worth $40,000 after acquiring an additional 1,011 shares during the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new position in Alignment Healthcare during the first quarter worth about $42,000. Amalgamated Bank raised its position in Alignment Healthcare by 21.6% during the first quarter. Amalgamated Bank now owns 3,466 shares of the company’s stock worth $65,000 after acquiring an additional 616 shares during the last quarter. RiverPark Advisors LLC acquired a new position in Alignment Healthcare during the fourth quarter worth about $106,000. Finally, Tower Research Capital LLC TRC raised its position in Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock worth $119,000 after acquiring an additional 6,286 shares during the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have issued reports on ALHC. UBS Group lifted their target price on shares of Alignment Healthcare from $16.00 to $17.00 and gave the stock a “neutral” rating in a research report on Friday, May 2nd. Zacks Research upgraded shares of Alignment Healthcare to a “hold” rating in a research report on Friday, August 8th. Stephens upgraded shares of Alignment Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. Barclays upgraded shares of Alignment Healthcare from an “underweight” rating to an “equal weight” rating and lifted their price target for the stock from $9.00 to $13.00 in a report on Thursday, July 31st. Finally, Wall Street Zen downgraded shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Sunday, August 10th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $18.56.

Alignment Healthcare Price Performance

ALHC opened at $15.02 on Thursday. The company’s 50 day simple moving average is $13.74 and its 200 day simple moving average is $15.29. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66. Alignment Healthcare, Inc. has a 1 year low of $8.24 and a 1 year high of $21.06. The stock has a market capitalization of $2.97 billion, a PE ratio of -53.64 and a beta of 1.16.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.14. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The business had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $960.25 million. During the same period last year, the company earned ($0.13) earnings per share. The company’s quarterly revenue was up 49.0% on a year-over-year basis. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, sell-side analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Insider Activity

In other Alignment Healthcare news, insider Robert L. Scavo sold 60,000 shares of Alignment Healthcare stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $14.60, for a total transaction of $876,000.00. Following the transaction, the insider directly owned 642,953 shares of the company’s stock, valued at $9,387,113.80. The trade was a 8.54% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Joseph S. Konowiecki sold 25,000 shares of Alignment Healthcare stock in a transaction that occurred on Thursday, July 31st. The shares were sold at an average price of $16.00, for a total transaction of $400,000.00. Following the transaction, the director directly owned 1,152,049 shares in the company, valued at approximately $18,432,784. This trade represents a 2.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 599,353 shares of company stock valued at $8,640,501 over the last quarter. 7.00% of the stock is owned by insiders.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.